CClinicalTrials.gg
CompletedNCT03288376SNORESOUNDSUpdated Aug 7, 2019

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

An observational study in Sleep Apnea, Obstructive and Chronic Obstructive Pulmonary Disease, sponsored by Incyphae, Inc.. Completed at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-07.

Sponsored by Incyphae, Inc. · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
272
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective multipart clinical performance study to compare the ability of the SnoreSounds algorithm with polysomnography (PSG) and a type III Home Sleep Testing (HST) device to identify patients with obstructive sleep apnea (OSA).

Read the detailed description

Consecutive patients referred to a sleep lab for possible OSA (obstructive sleep apnea) will be offered participation in this study. Study subjects will participate in either Part A, Part B or Part C of the study. Subjects will not participate in more than one part of the study. Study sites can participate in multiple parts of the study.

Part A: Sleep Lab

Consecutive patients referred to a sleep lab for possible OSA will be offered participation. Participants who provide informed consent will fill out a questionnaire and then have PSG, as it would normally be performed. During PSG additional sound recordings will be made in three ways:

  1. Microphone placed 50-100 cm (20-40 inches) from the patient's mouth.
  2. Android type Smart Phone with a recording application (app). The phone will be placed on a table 50-100 cm (20-40 inches)) from patient's mouth.
  3. iPhone type Smart Phone with a recording app. Phone will be placed on a table 50-100 cm (20-40 inches) from patient's mouth.

The sound recordings obtained via the microphone and Smart Phones will be analyzed electronically for OSA by the sponsor's proprietary algorithm. A blinded comparison will be made between the PSG results and SnoreSounds algorithm results.

PSG will be performed and scored in a manner consistent with current (2012) American Academy of Sleep Medicine (AASM) standards. PSGs will be scored twice - with each scoring performed independently. If the Apnea Hypopnea Index (AHI) for each score places the patient in the same OSA severity range [0-4 normal/minimal OSA, 5-14 mild, 15-30 moderate, >30 severe] the average of the two scores will be utilized. If however the scores put the patent in different OSA severity ranges, then the study will be scored by an independent sleep medicine physician-sleep technician team and assigned an AHI.

The results of the SnoreSounds testing will not be known to the sleep lab and the results obtained from Snore Sounds analysis will not be utilized in the clinical management of study participants.

Part B: Comparison of SnoreSounds algorithm to Home Sleep Testing (HST) (currently not enrolling in Part B)

Part C: Comparison of SnoreSounds algorithm to Home Sleep Testing (HST) and to Polysomnography (PSG) (currently not enrolling in Part C)

02

Conditions studied

  • Sleep Apnea, Obstructive
  • Chronic Obstructive Pulmonary Disease

Keywords

  • obstructive sleep apnea
  • polysomnography
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Men and women aged >or= 18 years who are referred for polysomnography (PSG) or Home Sleep Test (HST) because of possible obstructive sleep apnea (OSA).

Inclusion criteria

  • Patients >or= 18 years old who are referred for polysomnography (PSG) or Home Sleep Test (HST) because of possible obstructive sleep apnea (OSA)

Exclusion criteria

Exclusion Criteria:

  • Previous PSG or HST confirming OSA
  • Prior surgery for snoring or OSA
  • Medical contraindication for PSG
  • Cognitive impairment that might interfere with obtaining informed consent or completing Clinical Questionnaire
04

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
272 participants (actual)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Agreement between algorithm with PSG reference standard for detection of OSA at an AHI cut-off of 15

    Agreement between algorithm with PSG reference standard for detection of OSA at an AHI cut-off of 15

    Time frame: immediate

Secondary outcomes

  1. Comparison between algorithm and PSG assignment of OSA severity based on AHI [0-4 normal/minimal OSA, 5-14 mild, 15-30 moderate, >30 severe].

    Comparison between algorithm and PSG assignment of OSA severity based on AHI \[0-4 normal/minimal OSA, 5-14 mild, 15-30 moderate, \>30 severe\].

    Time frame: immediate

06

Study locations

3 sites
  • Peninsula Sleep Center
    Burlingame, California 94010, United States
  • Northeast Medical Group
    New London, Connecticut 06320, United States
  • Doctors Community Hospital
    Lanham, Maryland 20706, United States
07

References and documents

Publications

  • Pandian TNG, Sehra R, Narayan S. Breath variability increases in the minutes preceding obstructive sleep apneic events. Sleep Breath. 2021 Mar;25(1):271-280. doi: 10.1007/s11325-020-02094-1. Epub 2020 Jun 6. PubMed 32506203 ↗
  • Narayan S, Shivdare P, Niranjan T, Williams K, Freudman J, Sehra R. Noncontact identification of sleep-disturbed breathing from smartphone-recorded sounds validated by polysomnography. Sleep Breath. 2019 Mar;23(1):269-279. doi: 10.1007/s11325-018-1695-6. Epub 2018 Jul 18. PubMed 30022325 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03288376
Lead sponsor
Incyphae, Inc.
Responsible party
Sponsor
First posted
Sep 20, 2017
Start date
Feb 13, 2015
Primary completion
Jan 31, 2017
Completion
Jan 31, 2017
Last update
Aug 7, 2019

Study contacts

Ruchir Sehra, MD
principal investigator · Incyphae, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion